RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Sunny E. Ohia to Cyclic Nucleotide Phosphodiesterases, Type 4

Back to Details
This is a "connection" page, showing publications Sunny E. Ohia has written about Cyclic Nucleotide Phosphodiesterases, Type 4.
Sunny E. Ohia
Connection Strength
0.010
Cyclic Nucleotide Phosphodiesterases, Type 4
  1. Crocker IC, Ohia SE, Church MK, Townley RG. Phosphodiesterase type 4 inhibitors, but not glucocorticoids, are more potent in suppression of cytokine secretion by mononuclear cells from atopic than nonatopic donors. J Allergy Clin Immunol. 1998 Nov; 102(5):797-804.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support